血小板衍生生长因子-BB和血管内皮生长因子水平升高与重症疟疾贫血患儿再入院或死亡风险降低相关
在乌干达坎帕拉纳入145例18个月至12岁重症疟疾贫血患儿,检测入院时10种血管生长、造血及内皮功能生物标志物,随访12个月。校正年龄和性别后,血小板衍生生长因子-BB和血管内皮生长因子升高与全因再入院或死亡风险降低独立相关,主要由重症疟疾再入院风险降低驱动。
要点
- 入院时血小板衍生生长因子-BB和血管内皮生长因子升高与全因再入院或死亡风险降低独立相关。
- 上述关联主要由重症疟疾再入院风险降低驱动,与无并发症疟疾风险无关。
- 145例患儿随访12个月,19例再入院或死亡(15例再入院,其中13例疟疾;4例死亡)。
核心结论
- 重症疟疾贫血患儿入院时血浆血小板衍生生长因子-BB和血管内皮生长因子水平升高与入院后一年内再入院或死亡风险降低相关,主要由复发性重症疟疾风险降低驱动。
研究设计与样本
- 在乌干达坎帕拉纳入145例18个月至12岁重症疟疾贫血患儿,入院时采集血浆,随访12个月评估结局。
- 比较入院时10种血管生长、造血及内皮功能生物标志物血浆水平与12个月随访期间再入院或死亡风险。
主要发现
- 12个月随访期间,145例重症疟疾贫血患儿中19例再入院或死亡:15例再入院(其中13例为疟疾),4例死亡。
- 校正年龄和性别后,入院时血小板衍生生长因子-BB升高与全因再入院或死亡风险降低独立相关(校正风险比0.28,95%置信区间0.16-0.51)。
- 校正年龄和性别后,入院时血管内皮生长因子升高与全因再入院或死亡风险降低独立相关(校正风险比0.19,95%置信区间0.08-0.48)。
- 血小板衍生生长因子-BB和血管内皮生长因子升高与重症疟疾再入院风险降低相关(校正风险比分别为0.27,95%置信区间0.15-0.51;0.16,95%置信区间0.05-0.47)。
- 血小板衍生生长因子-BB和血管内皮生长因子升高与无并发症疟疾风险无关(校正风险比分别为1.01,95%置信区间0.53-1.95;2.07,95%置信区间0.93-4.64)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Children with severe malarial anemia (SMA) typically have low in-hospital mortality but have a high risk of postdischarge readmission or death. We hypothesized that the dysregulation of hematopoiesis, vascular growth factors, and endothelial function that occurs in SMA might affect risk of readmission or death. METHODS: Plasma was obtained from children 18 months to 12 years old with SMA (n = 145) in Kampala, Uganda on admission, and outcomes were assessed over 12-month follow-up. Admission plasma levels of 10 biomarkers of vascular growth, hematopoiesis, and endothelial function were compared to risk of readmission or death over 12-month follow-up. RESULTS: Over 12-month follow-up, 19 of 145 children with SMA were either readmitted or died: 15 children were readmitted (13 with malaria) and 4 children died. In multivariable analyses adjusted for age and sex, elevated plasma levels of platelet-derived growth factor-BB (PDGF-BB) and vascular endothelial growth factor (VEGF) on admission were independently associated with a decreased risk of all-cause readmission or death (adjusted hazard ratios [95% confidence intervals], 0.28 [.16-.51] and 0.19 [.08-.48], respectively) and a decreased risk of readmission due to severe malaria (0.27 [.15-.51] and 0.16 [.05-.47]) but not with risk of uncomplicated malaria (1.01 [.53-1.95] and 2.07 [.93-4.64]). CONCLUSIONS: In children with severe malarial anemia, elevated plasma levels of PDGF-BB and VEGF, 2 factors that promote angiogenesis, are associated with a decreased risk of readmission or death in the year following admission, primarily driven by a decrease in the risk of recurrent severe malaria.
引用
- Slaughter MG, Bhumbra S, Mellencamp KA, et al. Elevated Levels of PDGF-BB and VEGF Are Associated With a Decreased Risk of Readmission or Death in Children With Severe Malarial Anemia. J Infect Dis. 2025. PMID: 39449682. doi:10.1093/infdis/jiae527
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。